Elysia Larson (she/her), Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Maternal Health Services | 6 | 2019 | 455 | 1.540 |
Why?
|
| Patient Satisfaction | 5 | 2019 | 3396 | 1.040 |
Why?
|
| Tanzania | 12 | 2019 | 1346 | 0.890 |
Why?
|
| Quality Indicators, Health Care | 3 | 2019 | 1831 | 0.860 |
Why?
|
| Delivery, Obstetric | 4 | 2019 | 906 | 0.790 |
Why?
|
| Quality of Health Care | 6 | 2019 | 4371 | 0.770 |
Why?
|
| Health Facilities | 3 | 2019 | 573 | 0.670 |
Why?
|
| Rural Health Services | 4 | 2015 | 379 | 0.670 |
Why?
|
| Patient-Centered Care | 2 | 2019 | 1439 | 0.580 |
Why?
|
| Health Services Accessibility | 8 | 2017 | 5137 | 0.520 |
Why?
|
| Postnatal Care | 1 | 2017 | 236 | 0.510 |
Why?
|
| Anti-Retroviral Agents | 2 | 2013 | 1715 | 0.440 |
Why?
|
| Program Evaluation | 2 | 2019 | 2488 | 0.420 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2017 | 428 | 0.420 |
Why?
|
| Health Facility Administration | 1 | 2012 | 31 | 0.420 |
Why?
|
| Outpatients | 1 | 2019 | 1486 | 0.400 |
Why?
|
| Health Care Surveys | 3 | 2015 | 2453 | 0.400 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 3022 | 0.380 |
Why?
|
| Postpartum Period | 1 | 2017 | 1086 | 0.370 |
Why?
|
| Quality Improvement | 3 | 2019 | 3749 | 0.330 |
Why?
|
| Rural Population | 6 | 2019 | 2210 | 0.320 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 3843 | 0.310 |
Why?
|
| Prenatal Care | 4 | 2019 | 1092 | 0.300 |
Why?
|
| HIV Infections | 7 | 2019 | 16718 | 0.290 |
Why?
|
| Community Health Services | 3 | 2019 | 650 | 0.290 |
Why?
|
| Home Childbirth | 2 | 2019 | 51 | 0.290 |
Why?
|
| Research Design | 2 | 2019 | 5987 | 0.270 |
Why?
|
| Developing Countries | 1 | 2017 | 2815 | 0.250 |
Why?
|
| South Africa | 4 | 2013 | 1731 | 0.240 |
Why?
|
| Parents | 1 | 2017 | 3407 | 0.230 |
Why?
|
| Communication | 1 | 2017 | 3749 | 0.220 |
Why?
|
| Population Surveillance | 1 | 2013 | 2616 | 0.220 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 5319 | 0.220 |
Why?
|
| Parturition | 2 | 2019 | 441 | 0.220 |
Why?
|
| Healthcare Disparities | 3 | 2015 | 3158 | 0.210 |
Why?
|
| Pregnancy | 9 | 2019 | 29144 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 1320 | 0.180 |
Why?
|
| Cross-Sectional Studies | 6 | 2019 | 25043 | 0.150 |
Why?
|
| Liberia | 1 | 2017 | 167 | 0.150 |
Why?
|
| Hypertension | 1 | 2017 | 8480 | 0.140 |
Why?
|
| Anti-HIV Agents | 3 | 2019 | 4256 | 0.140 |
Why?
|
| Maternal Mortality | 1 | 2019 | 310 | 0.140 |
Why?
|
| International Cooperation | 2 | 2012 | 1420 | 0.130 |
Why?
|
| Primary Health Care | 3 | 2019 | 4558 | 0.130 |
Why?
|
| Adult | 15 | 2019 | 214055 | 0.130 |
Why?
|
| Capacity Building | 1 | 2017 | 248 | 0.130 |
Why?
|
| Africa South of the Sahara | 1 | 2017 | 724 | 0.120 |
Why?
|
| Health Priorities | 1 | 2017 | 380 | 0.120 |
Why?
|
| Young Adult | 10 | 2019 | 56430 | 0.120 |
Why?
|
| Poverty | 2 | 2017 | 2660 | 0.120 |
Why?
|
| Professional-Patient Relations | 1 | 2019 | 737 | 0.120 |
Why?
|
| Infant Mortality | 1 | 2019 | 754 | 0.120 |
Why?
|
| Syphilis | 1 | 2016 | 227 | 0.110 |
Why?
|
| Africa | 1 | 2015 | 673 | 0.110 |
Why?
|
| Professional-Family Relations | 1 | 2017 | 482 | 0.110 |
Why?
|
| Rural Health | 1 | 2014 | 305 | 0.110 |
Why?
|
| Adolescent | 9 | 2019 | 85781 | 0.110 |
Why?
|
| Female | 18 | 2019 | 380194 | 0.110 |
Why?
|
| Health Personnel | 2 | 2017 | 3218 | 0.100 |
Why?
|
| Epidemics | 1 | 2017 | 523 | 0.100 |
Why?
|
| Humans | 24 | 2019 | 744343 | 0.100 |
Why?
|
| Firearms | 1 | 2019 | 598 | 0.100 |
Why?
|
| Ambulatory Care Facilities | 2 | 2014 | 933 | 0.100 |
Why?
|
| Job Satisfaction | 1 | 2014 | 535 | 0.090 |
Why?
|
| Health Services Research | 2 | 2017 | 1836 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2019 | 25625 | 0.090 |
Why?
|
| Health Education | 1 | 2017 | 1056 | 0.090 |
Why?
|
| Government Programs | 1 | 2012 | 275 | 0.090 |
Why?
|
| Demography | 1 | 2014 | 1656 | 0.090 |
Why?
|
| Pregnant Women | 1 | 2014 | 568 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2016 | 1236 | 0.080 |
Why?
|
| National Health Programs | 1 | 2012 | 445 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2013 | 2297 | 0.080 |
Why?
|
| Infant | 4 | 2019 | 35136 | 0.080 |
Why?
|
| Suicide | 1 | 2019 | 1477 | 0.080 |
Why?
|
| Patient Preference | 1 | 2015 | 890 | 0.080 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 281 | 0.080 |
Why?
|
| Age Distribution | 1 | 2013 | 2902 | 0.080 |
Why?
|
| Socioeconomic Factors | 3 | 2019 | 7785 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 2046 | 0.070 |
Why?
|
| Logistic Models | 3 | 2017 | 13408 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12245 | 0.070 |
Why?
|
| Caregivers | 1 | 2017 | 2094 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2017 | 3923 | 0.070 |
Why?
|
| Emergency Medical Services | 1 | 2017 | 1917 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2013 | 1873 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2014 | 2052 | 0.060 |
Why?
|
| Hospitals | 2 | 2015 | 3952 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2016 | 2026 | 0.060 |
Why?
|
| Cause of Death | 1 | 2013 | 3584 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2011 | 2232 | 0.050 |
Why?
|
| Mortality | 1 | 2013 | 2864 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 2016 | 0.050 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2011 | 1624 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1345 | 0.050 |
Why?
|
| Parity | 2 | 2015 | 929 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8554 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 2645 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19905 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2019 | 2715 | 0.050 |
Why?
|
| Mass Screening | 1 | 2016 | 5255 | 0.050 |
Why?
|
| Prevalence | 1 | 2017 | 15226 | 0.040 |
Why?
|
| Public Health | 1 | 2012 | 2603 | 0.040 |
Why?
|
| Middle Aged | 4 | 2019 | 213383 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 13881 | 0.030 |
Why?
|
| Data Collection | 2 | 2015 | 3341 | 0.030 |
Why?
|
| Malawi | 1 | 2016 | 282 | 0.030 |
Why?
|
| Multilevel Analysis | 1 | 2015 | 142 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 6234 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2016 | 224 | 0.030 |
Why?
|
| Male | 7 | 2019 | 350118 | 0.030 |
Why?
|
| Child | 4 | 2019 | 77709 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 72290 | 0.030 |
Why?
|
| Work | 1 | 2014 | 191 | 0.030 |
Why?
|
| Censuses | 1 | 2014 | 200 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 9239 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5221 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2014 | 264 | 0.030 |
Why?
|
| Mediastinum | 1 | 2011 | 267 | 0.020 |
Why?
|
| Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
| Health Resources | 1 | 2014 | 911 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 20129 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2014 | 2539 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 1425 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13102 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2795 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 1915 | 0.020 |
Why?
|
| Respiration | 1 | 2011 | 1653 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2010 | 1275 | 0.010 |
Why?
|
| Movement | 1 | 2011 | 1471 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2010 | 1533 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9849 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4258 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3474 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2012 | 41006 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 8642 | 0.010 |
Why?
|
| United States | 2 | 2019 | 69872 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4042 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12788 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 4034 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6364 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39050 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 40075 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 57776 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 63114 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2010 | 77449 | 0.000 |
Why?
|
| Aged | 1 | 2011 | 163280 | 0.000 |
Why?
|